Patients with complex aneurysms in the visceral aorta, which supplies blood to vital abdominal organs, had limited treatment options, often requiring highly invasive open surgery with long recovery ...

It reported the medication was effective at increasing the rate of growth by 2.5cm a year for up to 18 months during treatment, increasing overall height and improving the upper-to-lower-body segment ...

Livionex, recently announced a successful end-of-Phase 2 meeting with the FDA, supporting the advancement of C-KAD, a 2.6% EDTA ophthalmic solution, to a Phase 3 clinical study. In an interview with ...